Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In March, the Danish developer revealed Phase I data for the oral asset, highlighting a 13.1% weight loss at 12 weeks, versus 1.1% for placebo
Semaglutide is a GLP-1 medication primarily prescribed for people with Type 2 diabetes, and is also US Food and Drug Administration (FDA)-approved for weight loss in people with obesity
Childrens doses are carefully calculated based on weight and infection type to ensure safety and effectiveness
US$ 29.70
US$ 27.55
US$ 29.17
US$ 22.55
US$ 28.45
US$ 22.87
US$ 21.08
